Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lebrikizumab in Patients With Uncontrolled Asthma
NCT01867125Phase 3Completed
- Sponsor
- Roche
- Start
- Jul 2013
- Primary completion
- Dec 2016
- Countries
- 26
01
Overview
A Phase 3 trial of lebrikizumab in asthma, sponsored by Roche. Started Jul 2013; status: completed.
02
Drugs
lebrikizumab
03
Conditions
asthma
Beyond the preview
Go deeper on NCT01867125.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01867125.